Table 2.
AE Description | Group |
|||
---|---|---|---|---|
Placebo (n = 20) |
Anti-CS6 (n = 19) |
Anti-B7A (n = 20) |
Total (n = 59) |
|
Abdominal cramps, n(%) | 1 (5.0) | 2 (10.5) | 0 (0.0) | 3 (5.1) |
Anorexia, n(%) | 0 (0.0) | 0 (0.0) | 1 (5.0) | 1 (1.7) |
Bloating, n(%) | 0 (0.0) | 1 (5.3) | 2 (10.0) | 3 (5.1) |
Flatulence, n(%) | 2 (10.0) | 3 (15.8) | 4 (20.0) | 9 (15.3) |
Headache, n(%) | 0 (0.0) | 0 (0.0) | 2 (10.0) | 2 (3.4) |
Nausea, n(%) | 0 (0.0) | 0 (0.0) | 1 (5.0) | 1 (1.7) |
Urgency, n(%) | 1 (5.0) | 0 (0.0) | 0 (0.0) | 1 (1.7) |
All reported symptoms were mild except for 1 moderate episode of abdominal cramps.